Clinical Trial of CD19 CAR-T Cell Therapy with non-virus Vector System

被引：0
|
作者：
Takahashi, Yoshiyuki [1 ]
机构：
[1] Nagoya Univ, Dept Pediat, Nagoya, Aichi, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2017年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY5-1
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
  • [41] Infectious complications among CD19 CAR-T cell therapy recipients: A single-center experience
    Walker, Bryan
    Zimmer, Andrea J.
    Stohs, Erica J.
    Lunning, Matthew
    Lyden, Elizabeth
    Abbas, Anum
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25
  • [42] Tandem CD19/CD22 Dual Targets CAR-T Cells Therapy Obtains Superior CR Rate Than Single CD19 CAR-T Cells Infusion As Well As Sequential CD19 and CD22 CAR-T Cells Infusion for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients
    Liu, Sining
    Zhang, Xinyue
    Dai, Haiping
    Cui, Qingya
    Cui, Wei
    Yin, Jia
    Li, Zheng
    Xue, Shengli
    Yang, Chunxiu
    Yang, Xiao
    Qiu, Huiying
    Miao, Miao
    Chen, Suning
    Jin, Zhengming
    Fu, Chengcheng
    Li, Caixia
    Sun, Aining
    Han, Yue
    Wang, Ying
    Yu, Lei
    Wu, Depei
    Tang, Xiaowen
    BLOOD, 2021, 138
  • [43] Clinical implications for CAR T cell persistence and functional phenotype in patients treated with CD19 CAR T cell therapy.
    Bochnacka, Oliwia
    Quinn, Suzanne
    Dalheim, Annika
    Scurti, Gina
    Hossain, Nasheed
    Nishimura, Michael
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [44] Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy
    Sheih, Alyssa
    Voillet, Valentin
    Hanafi, Laila-Aicha
    DeBerg, Hannah A.
    Yajima, Masanao
    Hawkins, Reed
    Gersuk, Vivian
    Riddell, Stanley R.
    Maloney, David G.
    Wohlfahrt, Martin E.
    Pande, Dnyanada
    Enstrom, Mark R.
    Kiem, Hans-Peter
    Adair, Jennifer E.
    Gottardo, Raphael
    Linsley, Peter S.
    Turtle, Cameron J.
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [45] Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy
    Alyssa Sheih
    Valentin Voillet
    Laïla-Aïcha Hanafi
    Hannah A. DeBerg
    Masanao Yajima
    Reed Hawkins
    Vivian Gersuk
    Stanley R. Riddell
    David G. Maloney
    Martin E. Wohlfahrt
    Dnyanada Pande
    Mark R. Enstrom
    Hans-Peter Kiem
    Jennifer E. Adair
    Raphaël Gottardo
    Peter S. Linsley
    Cameron J. Turtle
    Nature Communications, 11
  • [46] Development of a translatable CD19 CAR-T platform for drug discovery
    Kelsey, Lauren
    Self-Fordham, Jezrom
    Oswald, Eva
    Aylott, Ilona
    Rocca, Daniel
    Nunan, Robert
    Harris, David
    Schueler, Julia
    Jenkinson, Rhiannon
    CANCER RESEARCH, 2022, 82 (12)
  • [47] Two years later: CD19 CAR-T going the distance
    Darnell, Eli P.
    Frigault, Matthew J.
    BLOOD, 2024, 143 (05) : 379 - 380
  • [48] Challenge of cryopreservation for gmp grade CD19 CAR-T cells
    Gong, Wenjie
    Wang, Lei
    Wang, Sanmei
    Neuber, Brigitte
    Sellner, Leopold
    Schubert, Maria-Luisa
    Hueckelhoven-Krauss, Angela
    Kunz, Alexander
    Gern, Ulrike
    Michels, Birgit
    Hinkelbein, Mandy
    Mechler, Stefanie
    Richter, Petra
    Mueller-Tidow, Carsten
    Dreger, Peter
    Schmitt, Michael
    Schmitt, Anita
    BONE MARROW TRANSPLANTATION, 2019, 54 : 186 - 187
  • [49] Detail Analysis of Non-Specific Activation of CD19 CAR-T Cells Caused by CAR Design
    Okamoto, Sachiko
    Amaishi, Yasunori
    Pei, Zheng
    Mineno, Junichi
    MOLECULAR THERAPY, 2015, 23 : S84 - S85
  • [50] CD19 CAR-T Cell Therapy at the LMU Munich from 2019 to 2021: Increasing Therapy Safety over the Years
    Bucklein, V
    Blumenberg, V
    Frolich, L.
    Ackermann, J.
    Schmidt, C.
    Hildebrand, F.
    Rejeski, K.
    Winkelmann, M.
    Schoberl, F.
    Kunz, W.
    Von Baumgarten, L.
    Humpe, A.
    Von Bergwelt, M.
    Subklewe, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 125 - 125
12345